ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,195.20
      -0.57%
      Dow Jones
      40,358.09
      -0.16%
      Brent Oil
      80.775
      -0.91%
      Bitcoin
      66,016.34
      -2.35%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Immunocore Holdings PLC (IMCR) Quote

      Immunocore Holdings PLC

      Immunocore Holdings PLC (IMCR)

      NASDAQ
      39.22
      -0.06
      (-0.15%)
      At close: July 23 4:00PM
      Delayed by 15 minutes
      39.22
      -0.06
      ( -0.15% )
      After Hours: 5:30PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      39.22
      Bid
      37.31
      Ask
      40.17
      Volume
      138,631
      38.44 Day's Range 39.46
      0.00 52 Week Range 0.00
      Market Cap
      1.886B
      Previous Close
      39.28
      Open
      38.99
      Last Trade
      46
      @
      39.22
      Last Trade Time
      17:03:16
      Financial Volume
      $ 5,411,160
      VWAP
      39.0328
      Average Volume (3m)
      -
      Shares Outstanding
      48,088,346
      Dividend Yield
      -
      PE Ratio
      -34.17
      Earnings Per Share (EPS)
      -1.15
      Revenue
      249.43M
      Net Profit
      -55.29M

      About Immunocore Holdings PLC

      Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority o... Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States. Show more

      Sector
      Noncomml Resh Organizations
      Industry
      Noncomml Resh Organizations
      Website
      www.immunocore.com
      Headquarters
      Oxfordshire, Gbr
      Founded
      1970
      Immunocore Holdings PLC is listed in the Noncomml Resh Organizations sector of the NASDAQ with ticker IMCR. The last closing price for Immunocore was $39.28. Over the last year, Immunocore shares have traded in a share price range of $ 0.00 to $ 0.00.

      Immunocore currently has 48,088,346 shares outstanding. The market capitalization of Immunocore is $1.89 billion. Immunocore has a price to earnings ratio (PE ratio) of -34.17.

      IMCR Latest News

      More News

      Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

      Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous...

      June 18 2024
      GlobeNewswire Inc.

      Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

      Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response Data were...

      June 01 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 31 2024
      Edgar (US Regulatory)

      Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

      Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 Monotherapy...

      May 31 2024
      GlobeNewswire Inc.

      Immunocore to present at the Jefferies Global Healthcare Conference

      Immunocore to present at the Jefferies Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 30 May 2024) Immunocore Holdings plc (Nasdaq: IMCR...

      May 30 2024
      GlobeNewswire Inc.

      Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

      Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with...

      May 29 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 28 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 28 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 28 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 28 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALLRAllarity Therapeutics Inc
      $ 0.2901
      (74.23%)
      		35.57M
      NIVFNewGenIvf Group Ltd
      $ 1.46
      (67.64%)
      		3.46M
      SLNASelina Hospitality PLC
      $ 0.031
      (19.23%)
      		35.07M
      DRMADermata Therapeutics Inc
      $ 1.44
      (10.77%)
      		92.23k
      TRIBTrinity Biotech PLC
      $ 3.35
      (9.48%)
      		826
      VSTMVerastem Inc
      $ 2.67
      (-25.63%)
      		365.05k
      SLRXSalarius Pharmaceuticals Inc
      $ 2.17
      (-16.86%)
      		202.8k
      ALPPAlpine 4 Holdings Inc
      $ 0.5119
      (-14.67%)
      		283.36k
      CJETChijet Motor Company Inc
      $ 4.36
      (-14.17%)
      		87.52k
      GERNGeron Corp
      $ 4.01
      (-13.20%)
      		546.62k
      ALLRAllarity Therapeutics Inc
      $ 0.2901
      (74.23%)
      		35.57M
      SLNASelina Hospitality PLC
      $ 0.031
      (19.23%)
      		35.07M
      TSLATesla Inc
      $ 235.97
      (-4.23%)
      		11.77M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 12.52
      (-8.61%)
      		9.95M
      HOLOMicroCloud Hologram Inc
      $ 0.6139
      (4.98%)
      		8.34M

      IMCR Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      IMCR over $30
      👍️0

      Your Recent History

      NASDAQ
      IMCR
      Immunocore
      BINA
      TIABTC
      TAI
      Delayed Upgrade Clock